Table 2.

Cancer incidence by histologic grouping^a among rare and non-rare cancer sites:^b adults, 41 U.S. registries combined, 1995–2004

Source: North American Association of Central Cancer Registries file submission as of December 2006 from: Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, Washington, D.C., Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Massachusetts, Detroit, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Texas, Utah, Washington, West Virginia, Wisconsin, and Wyoming

^aHistology classification using groupings shown in: Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.

^bClassification by SEER site recode: Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al., editors. SEER Cancer Statistics Review, 1975–2004. Bethesda (MD): National Cancer Institute; 2007. Also available from: URL: http://seer.cancer.gov/csr/1975_2004 [cited 2008 Sep 25].

^cCancers occurring at rare sites with an incidence rate of <150 per million per year

^dRates are invasive, microscopically confirmed cancers per million per year and age-adjusted to the 2000 U.S. Standard Population (Census P25-1130).

NOS = not otherwise specified